Jemma You have asked some of very serious questions, your post...

First 2 Last

Share
Profile

Follow
truliapro

87 Posts.

21/02/15

06:55

Post #: 14794785
Share

Originally posted by jemma08 ↑

I have spent some time reading through some of the old messages on this forum as I am new to the company:

Thanks for all the very informative posts DONMAN, J8, Hoyland, drafter, Maxine and others (including Dr KSS)

One thing I am failing to comprehend is WHY you all so convinced of safety, let alone efficacy of ddRNAI and more specifically TT-034?

There seems to be NO human data which substantiates both safety, let alone efficacy yet...

- Why did Pfizer walk away from Tacere? I think there is more than just a re-allocation of resources?
- Why did many mice die in some previous tests? dosage questions?
- Why have others such as Mark Kay from Voyager said that Benitec are using the wrong 'Vector'?
- How can you be confident of success when in reality a trial marker for TT-034 seems to be the consistent eradication of any relapse? ie, any future relapse in time would deem the 'on-shot cure' a failure?

Consequently - could it be another 10 years before ddRNAI is even taken seriously and will the patents last that long or their technology be so much more advanced than other deep pocket nulti billion dollar RNAI technologies which have hundreds of compounds already in the labs?

Thanks again for all your interesting posts in the past and I look forward to following this forum with interst, but can't bring myself to take the punt on BLT. Too many questions unanswered. Benitec as an investment proposition could be dead money for a very long time. Although I am happy to hear why the long-term followers on here are convinced that assertion is wrong?

Jemma

Expand

Jemma
You have asked some of very serious questions, your post can be removed!!
In this forum you are allowed to speak only positive about tt-034.

For some people here BLT is emotional investment.

BLT Price at posting: 93.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

AZY

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

ENV

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

MLS

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

MKG

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

MM8

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

VUL

Vulcan appoints investment bank and M&A veteran to board

There are more pages in this discussion • 44 more messages in this thread...

First 2 Last

Add BLT (ASX) to my watchlist

Jemma You have asked some of very serious questions, your post...

Top Stories

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Utah authorities sign off on Anson's lithium extraction plans at Green River

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Vulcan appoints investment bank and M&A veteran to board

Featured News